34227-72-0

Usage

Uses

Used in Pharmaceutical Industry:
C14 Ceramide is used as an intermediate in the synthesis of various pharmaceutical compounds. Its unique chemical properties make it a valuable building block for the development of new drugs targeting various diseases.
Used in Cosmetic Industry:
C14 Ceramide is used as an active ingredient in the formulation of cosmetics and skincare products. It is known for its ability to maintain the skin's natural barrier, improve skin hydration, and reduce the appearance of fine lines and wrinkles.
Used in Research and Development:
C14 Ceramide is used as a research tool in the study of cellular processes and the development of new therapeutic strategies. Its role in cell signaling and growth makes it an important compound for understanding the underlying mechanisms of various diseases and conditions.
Used in Organic Synthesis:
C14 Ceramide is used as a starting material or intermediate in the synthesis of complex organic molecules. Its unique structure and properties make it a versatile building block for the creation of new compounds with potential applications in various industries.

InChI:InChI=1/C32H63NO3/c1-3-5-7-9-11-13-15-16-18-19-21-23-25-27-31(35)30(29-34)33-32(36)28-26-24-22-20-17-14-12-10-8-6-4-2/h25,27,30-31,34-35H,3-24,26,28-29H2,1-2H3,(H,33,36)/b27-25+/t30-,31+/m0/s1

Upstream product

• 123-78-4 (2S,3R,4E)-2-amino-4-octadecene-1,3-diol 
• 112-64-1 tetradecanoyl chloride 
• 96040-13-0 2-nitro-4-octadecine-1,3-diol 
• 2733-33-7 (+/-)-threo-2-amino-octadec-4-yne-1,3-diol 
• 123-78-4 dl-threo-sphingosine 
• 2673-72-5 (2S,3R,E)-2-aminooctadec-4-ene-1,3-diol hydrochloride 

Downstream Products

• 17673-67-5 DL-threo-1-(Triphenylmethoxy)-2-myristoylamino-3-hydroxy-trans-octadecen-⁽⁴⁾ 

Relevant academic research and scientific papers

Chiral combinatorial preparation and biological evaluation of unique ceramides for inhibition of sphingomyelin synthase

Enantiomers or diastereomers of chiral bioactive compounds often exhibit different biological and toxicological properties. Here, we report the efficient synthesis of four stereoisomers of sphingosine and derivatization of unique chiral ceramides through a combinatorial chemistry by solid-phase activated resin ester. In addition, to test the effectivity of stereochemistry of ceramide, we demonstrated a cell-based assay of sphingomyelin synthase inhibition in the presence ofchiral unique ceramides, which suggested that libraries of this sort will be a rich source of biologically active synthetic molecules.

Ceramide compound and application

The invention relates to a ceramide compound; in the structural general formula, m=2-12; n=0-20. The ceramide compound has significant pseudo neural growth factor activity, and is the small molecule compound capable of passing through blood-brain barrier. The structural general formula is shown as Figure.

Inhibitory activity of a ceramide library on interleukin-4 production from activated T cells

Allergic diseases are hypersensitivity disorders associated with the production of specific immunoglobulin E (IgE) to environmental allergens. Interleukin (IL)-4, produced primarily by CD4+ T cells, is an important stimulus for the switch of th

The synthesis and biological characterization of a ceramide library

A facile synthesis of a combinatorial ceramide library and their activities in the NF-κB pathway and in apoptosis induction/prevention were demonstrated. A novel NF-κB activating molecule was discovered among ceramide containing β-galactose, and the structural requirements of ceramides for apoptosis induction was elucidated. Copyright